J Cancer Prev 2023; 28(2): 40-46
Published online June 30, 2023
https://doi.org/10.15430/JCP.2023.28.2.40
© Korean Society of Cancer Prevention
Min Chang Oh1,* , Pincha Devage Sameera Madushan Fernando1,* , Mei Jing Piao1,2 , Kyoung Ah Kang1,2 , Herath Mudiyanselage Udari lakmini Herath1 , Jin Won Hyun1,2
1Department of Biochemistry, Jeju National University College of Medicine, 2Jeju Research Center for Natural Medicine, Jeju National University, Jeju, Korea
Correspondence to :
Jin Won Hyun, E-mail: jinwonh@jejunu.ac.kr, https://orcid.org/0000-0002-3403-3762
*These authors contributed equally to this work as co-first authors.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Excessive UVB exposure causes development of both malignant and non-malignant melanoma via the secretion of α-melanocyte-stimulating hormone (α-MSH). We investigated whether baicalein (5,6,7-trihydroxyflavone) could inhibit α-MSH-stimulated melanogenesis. Baicalein prevented UVB- and α-MSH-induced melanin production and attenuated α-MSH-stimulated tyrosinase (monophenol monooxygenase) activity, and expression of tyrosinase and tyrosine-related protein-2. In addition, baicalein prevented melanogenesis and pigmentation via the p38 mitogen-activated protein kinases signaling pathway. These findings suggest that baicalein represents a natural compound for attenuating melanogenesis.
Keywords: &alpha,-Melanocyte-stimulating hormone, Baicalein, Carcinogenesis, Monophenol monooxygenase, B16F10 cells
Jun Lee, Dong Yeop Shin, Yujin Jang, Jun Pyo Han, Eun-Min Cho, Young Rok Seo
J Cancer Prev 2023; 28(4): 150-159 https://doi.org/10.15430/JCP.2023.28.4.150Rakhi Issrani, Jagat Reddy, Tarek H. El-Metwally Dabah, Namdeo Prabhu
J Cancer Prev 2022; 27(1): 16-21 https://doi.org/10.15430/JCP.2022.27.1.16Jun Hyuek Yang, Preeyaporn Koedrith, Doo Seok Kang, Nam Kook Kee, Jong-Hyeon Jung, Cheol Min Lee, Yeon-Soon Ahn, Young Rok Seo
J Cancer Prev 2019; 24(3): 139-145 https://doi.org/10.15430/JCP.2019.24.3.139